Note: There is a maximum of 200 words per comment. If you wish to post more, please visit our forum.
Study raps Web sites touting stem cell therapies
Wednesday, December 03, 2008 | No comments posted.
NEW YORK (AP) — Consumers should be wary of Web sites from clinics that offer stem cell treatments, says a study that found a lack of firm medical evidence to back up their claims.
The Web sites in the study generally portrayed their therapies as safe, effective and ready for use, but published research doesn’t support that “overoptimistic” picture, the study authors said.
The analysis is presented in the December issue of the journal Cell Stem Cell by scientists at the University of Alberta in Canada. They cautioned that their overall findings can’t be applied to the claims of any individual clinic.
The study is “a very important wake-up call,” said Dr. George Daley, past president of the International Society for Stem Cell Research, who had no role in the new report.
“I think these Web sites are dangerous,” said Daley, a Boston stem cell researcher. “They overpromise effectiveness and safety of the therapy and they completely underestimate and underinform about risks. ... (Such) overhyped marketing directly to the patient is putting patients at risk of financial exploitation at the very least, and physical danger at the worst.”
In recent years, desperate patients with few options have traveled to China and other countries where doctors offer stem cell or other cell treatments for such things as spinal cord injuries, Parkinson’s disease and blindness.
In that issue, a report from the international stem cell society describes new research guidelines that condemn the marketing of unproven therapies.
The new study did not assess the Web site claims directly by checking on how well patients actually fared at the clinics in the study.
Instead, researchers began with the 19 Web sites they found through Google in 2007. Treatments were promoted in several countries, including China, Mexico and Russia. None promoted treatments within the United States; one didn’t give a location for treatments.
Last July, the researchers looked for published studies in human patients about using stem cells to treat the medical conditions mentioned most often by the Web sites: multiple sclerosis, Parkinson’s and Alzheimer’s diseases, spinal cord injury, stroke and heart attack.
They reported finding some encouraging hints but no clear evidence of benefit.
The Web sites in the study generally portrayed their therapies as safe, effective and ready for use, but published research doesn’t support that “overoptimistic” picture, the study authors said.
The analysis is presented in the December issue of the journal Cell Stem Cell by scientists at the University of Alberta in Canada. They cautioned that their overall findings can’t be applied to the claims of any individual clinic.
The study is “a very important wake-up call,” said Dr. George Daley, past president of the International Society for Stem Cell Research, who had no role in the new report.
“I think these Web sites are dangerous,” said Daley, a Boston stem cell researcher. “They overpromise effectiveness and safety of the therapy and they completely underestimate and underinform about risks. ... (Such) overhyped marketing directly to the patient is putting patients at risk of financial exploitation at the very least, and physical danger at the worst.”
In recent years, desperate patients with few options have traveled to China and other countries where doctors offer stem cell or other cell treatments for such things as spinal cord injuries, Parkinson’s disease and blindness.
In that issue, a report from the international stem cell society describes new research guidelines that condemn the marketing of unproven therapies.
The new study did not assess the Web site claims directly by checking on how well patients actually fared at the clinics in the study.
Instead, researchers began with the 19 Web sites they found through Google in 2007. Treatments were promoted in several countries, including China, Mexico and Russia. None promoted treatments within the United States; one didn’t give a location for treatments.
Last July, the researchers looked for published studies in human patients about using stem cells to treat the medical conditions mentioned most often by the Web sites: multiple sclerosis, Parkinson’s and Alzheimer’s diseases, spinal cord injury, stroke and heart attack.
They reported finding some encouraging hints but no clear evidence of benefit.
The comments below are from users of theworldlink.com and do not necessarily represent the views of The World or Lee Enterprises. Participation Guidelines
Note: There is a maximum of 200 words per comment. If you wish to post more, please visit our forum.
Note: There is a maximum of 200 words per comment. If you wish to post more, please visit our forum.
Not already registered?
The World welcomes your comments about stories, and we encourage a robust dialogue on this site. All comments must meet reasonable standards of decency and civility.
Please follow these basic rules:
- No defamatory comments about individuals or businesses.
- No deliberately false information.
- No obscenity or racially offensive language.
- No harassment, verbal abuse, threats or personal attacks.
- No information that invades another person's privacy.
- No business solicitations or charitable solicitations.
Comments that violate these standards will not be posted. Users with repeated violations may be banned from future posting.Comments will be approved throughout the day during business hours. After hours and weekend comments may not appear until the following business day. It may take a couple of hours before comments are approved.
The World generally does not edit comments, but we reserve the right to edit any comment that does not meet our standards.
Close Guidelines